{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:47:51Z","timestamp":1791960471215,"version":"4.3.4"},"reference-count":77,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2016,1,2]]},"DOI":"10.3109\/09273948.2015.1077976","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T23:03:10Z","timestamp":1449874990000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis"],"prefix":"10.3109","volume":"24","author":[{"given":"Rowayda M.","family":"Amin","sequence":"first","affiliation":[{"name":",","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Miserocchi","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[{"name":",","place":["USA"]},{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hornbeak","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[{"name":",","place":["USA"]},{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Zierhut","sequence":"additional","affiliation":[{"name":",","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.815785"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.791701"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.800561"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200312000-00013"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.01.033"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30329-7"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.016"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273940590951061"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.025"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.1.51"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(04)80026-7"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(03)00084-5"},{"key":"e_1_3_1_14_1","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001","volume":"31","author":"Petty RE","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol. 2004;31:390\u2013392.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(75)90529-2"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273940590909220"},{"key":"e_1_3_1_17_1","first-page":"2446","article-title":"Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis","volume":"29","author":"Zulian F","year":"2002","unstructured":"Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29:2446\u20132253.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00225-3"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.855798"},{"key":"e_1_3_1_20_1","article-title":"Methotrexate is protective against the new onset of uveitis under etanercept treatment. Data from the German Etanercept Registry","volume":"69","author":"Foeldvari I","year":"2010","unstructured":"Foeldvari I, Thme N, Horneff G. Methotrexate is protective against the new onset of uveitis under etanercept treatment. Data from the German Etanercept Registry. Ann Rheum. 2010;69(3):626.","journal-title":"Ann Rheum"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.12.003"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.10.008"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.025"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.052"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.12703\/P6-41"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.11.014"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2084-7"},{"key":"e_1_3_1_28_1","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari I","year":"2005","unstructured":"Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2005;32:362\u2013365.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70232-X"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210701700509"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.08.021"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.173542"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.094698"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.23"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.12.011"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.174"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"e_1_3_1_38_1","article-title":"Treatment of uveitis associated with juvenile idiopathic arthritis","volume":"16","author":"Bou R","year":"2014","unstructured":"Bou R, Iglesias E, Ant\u00f3n J. Treatment of uveitis associated with juvenile idiopathic arthritis. Curr Rheumatol Rep. 2014;16(8):437.","journal-title":"Curr Rheumatol Rep"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S41477"},{"key":"e_1_3_1_40_1","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0454-3","article-title":"Judicious use of biologicals in juvenile idiopathic arthritis","volume":"16","author":"Zhao Y","year":"2014","unstructured":"Zhao Y, Wallace C. Judicious use of biologicals in juvenile idiopathic arthritis. Curr Rheumatol Rep. 2014;16(11):454.","journal-title":"Curr Rheumatol Rep"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200406030-00001"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0654-6"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2012.723107"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S54207"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-14"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2275-x"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.06.009"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20904"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel030"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.058248"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.08.018"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.01.005"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.09.037"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken298"},{"issue":"5","key":"e_1_3_1_56_1","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari I","year":"2007","unstructured":"Foeldvari I, Nielsen S, Kummerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34(5):1146\u20131150.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_57_1","article-title":"Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series","volume":"24","author":"La Torre F","year":"2014","unstructured":"La Torre F, Cattalini M, Teruzzi B, et al. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series. BMC Res Notes. 2014;24:7:316.","journal-title":"BMC Res Notes"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.018"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem356"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S23646"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38741"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.103721"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303935"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-11-16"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120583"},{"key":"e_1_3_1_66_1","first-page":"320","article-title":"Golimumab treatment for complicated uveitis","volume":"31","author":"Miserocchi E","year":"2013","unstructured":"Miserocchi E, Modorati G, Pontikaki I, et al. Golimumab treatment for complicated uveitis. Clin Exp Rheumatol. 2013;31:320\u2013321.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.844265"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-010-1523-6"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20115"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20115"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140410"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.866254"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker107"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.07.001"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes212"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu457"},{"issue":"13","key":"e_1_3_1_77_1","first-page":"1266","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission a randomized clinical trial","volume":"303","author":"Foell D","year":"2010","unstructured":"Foell D, Wulffraat N, Wedderburn LR. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission a randomized clinical trial. JAMA Ophthalmol. 2010;303(13):1266\u20131273.","journal-title":"JAMA Ophthalmol"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.812222"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/09273948.2015.1077976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:43:31Z","timestamp":1772732611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/09273948.2015.1077976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,2]]}},"alternative-id":["10.3109\/09273948.2015.1077976"],"URL":"https:\/\/doi.org\/10.3109\/09273948.2015.1077976","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}